191 related articles for article (PubMed ID: 36540414)
1. Andrographolide-based potential anti-inflammatory transcription inhibitors against nuclear factor NF-kappa-B p50 subunit (NF-κB p50): an integrated molecular and quantum mechanical approach.
Jain P; Sudandiradoss C
3 Biotech; 2023 Jan; 13(1):15. PubMed ID: 36540414
[TBL] [Abstract][Full Text] [Related]
2. Discovery of andrographolide hit analog as a potent cyclooxygenase-2 inhibitor through consensus MD-simulation, electrostatic potential energy simulation and ligand efficiency metrics.
Jain P; Satija J; Sudandiradoss C
Sci Rep; 2023 May; 13(1):8147. PubMed ID: 37208387
[TBL] [Abstract][Full Text] [Related]
3. Targeting the NF-κB/IκBα complex via fragment-based E-Pharmacophore virtual screening and binary QSAR models.
Kanan T; Kanan D; Erol I; Yazdi S; Stein M; Durdagi S
J Mol Graph Model; 2019 Jan; 86():264-277. PubMed ID: 30415122
[TBL] [Abstract][Full Text] [Related]
4. A molecular modeling study of inhibitors of nuclear factor kappa-B (p50)--DNA binding.
Pande V; Sharma RK; Inoue J; Otsuka M; Ramos MJ
J Comput Aided Mol Des; 2003 Dec; 17(12):825-36. PubMed ID: 15124931
[TBL] [Abstract][Full Text] [Related]
5. Integrated molecular modeling and dynamics approaches revealed potential natural inhibitors of NF-κB transcription factor as breast cancer therapeutics.
Zubair M; Khalil S; Rasul I; Nadeem H; Noor F; Ahmad S; Alrumaihi F; Allemailem KS; Almatroudi A; Alshehri FF; Alshehri ZS
J Biomol Struct Dyn; 2023; 41(24):14715-14729. PubMed ID: 37301608
[TBL] [Abstract][Full Text] [Related]
6. Identification of potential andrographolide-based drug candidate against Keap1-Nrf2 pathway through rigorous cheminformatics screening.
Jain P; Sudandira Doss C
Mol Divers; 2023 Feb; 27(1):341-356. PubMed ID: 35467270
[TBL] [Abstract][Full Text] [Related]
7. Docking of molecules identified in bioactive medicinal plants extracts into the p50 NF-kappaB transcription factor: correlation with inhibition of NF-kappaB/DNA interactions and inhibitory effects on IL-8 gene expression.
Piccagli L; Fabbri E; Borgatti M; Bezzerri V; Mancini I; Nicolis E; Dechecchi MC; Lampronti I; Cabrini G; Gambari R
BMC Struct Biol; 2008 Sep; 8():38. PubMed ID: 18768082
[TBL] [Abstract][Full Text] [Related]
8. Specificity and inhibitory mechanism of andrographolide and its analogues as antiasthma agents on NF-κB p50.
Nguyen VS; Loh XY; Wijaya H; Wang J; Lin Q; Lam Y; Wong WS; Mok YK
J Nat Prod; 2015 Feb; 78(2):208-17. PubMed ID: 25615020
[TBL] [Abstract][Full Text] [Related]
9. Prediction of dual NF-κB/IκB inhibitors using an integrative
Abbasi M; Mahboubi-Rabbani M; Kashfi K; Sadeghi-Aliabadi H
J Biomol Struct Dyn; 2023; 41(23):14164-14178. PubMed ID: 36789516
[TBL] [Abstract][Full Text] [Related]
10. Virtual screening against p50 NF-kappaB transcription factor for the identification of inhibitors of the NF-kappaB-DNA interaction and expression of NF-kappaB upregulated genes.
Piccagli L; Fabbri E; Borgatti M; Bianchi N; Bezzerri V; Mancini I; Nicolis E; Dechecchi CM; Lampronti I; Cabrini G; Gambari R
ChemMedChem; 2009 Dec; 4(12):2024-33. PubMed ID: 19806632
[TBL] [Abstract][Full Text] [Related]
11. The tumor suppressor Sef is a scaffold for the classical NF-κB/RELA:P50 signaling module.
Korsensky L; Haif S; Heller R; Rabinovitz S; Haddad-Halloun J; Dahan N; Ron D
Cell Signal; 2019 Jul; 59():110-121. PubMed ID: 30862497
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms of interleukin-10-mediated inhibition of NF-kappaB activity: a role for p50.
Driessler F; Venstrom K; Sabat R; Asadullah K; Schottelius AJ
Clin Exp Immunol; 2004 Jan; 135(1):64-73. PubMed ID: 14678266
[TBL] [Abstract][Full Text] [Related]
13. In Silico Insights on the Pro-Inflammatory Potential of Polycyclic Aromatic Hydrocarbons and the Prospective Anti-Inflammatory Capacity of
Julaton T; Taclendo A; Oyong G; Rempillo O; Galvez MC; Vallar E
Int J Environ Res Public Health; 2022 Jul; 19(14):. PubMed ID: 35886440
[TBL] [Abstract][Full Text] [Related]
14. Transcription factor NF-κB as target for SARS-CoV-2 drug discovery efforts using inflammation-based QSAR screening model.
Kanan T; Kanan D; Al Shardoub EJ; Durdagi S
J Mol Graph Model; 2021 Nov; 108():107968. PubMed ID: 34311260
[TBL] [Abstract][Full Text] [Related]
15. In Silico and In Vitro Screening of 50 Curcumin Compounds as EGFR and NF-κB Inhibitors.
Saeed MEM; Yücer R; Dawood M; Hegazy MF; Drif A; Ooko E; Kadioglu O; Seo EJ; Kamounah FS; Titinchi SJ; Bachmeier B; Efferth T
Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409325
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of transcription by B cell Leukemia 3 (Bcl-3) protein requires interaction with nuclear factor κB (NF-κB) p50.
Collins PE; Kiely PA; Carmody RJ
J Biol Chem; 2014 Mar; 289(10):7059-7067. PubMed ID: 24459141
[TBL] [Abstract][Full Text] [Related]
17.
Pattnaik S; Murmu S; Prasad Rath B; Singh MK; Kumar S; Mohanty C
J Biomol Struct Dyn; 2024 Jan; ():1-29. PubMed ID: 38287503
[TBL] [Abstract][Full Text] [Related]
18. Investigation of the New Inhibitors by Sulfadiazine and Modified Derivatives of α-D-glucopyranoside for White Spot Syndrome Virus Disease of Shrimp by In Silico: Quantum Calculations, Molecular Docking, ADMET and Molecular Dynamics Study.
Kumer A; Chakma U; Rana MM; Chandro A; Akash S; Elseehy MM; Albogami S; El-Shehawi AM
Molecules; 2022 Jun; 27(12):. PubMed ID: 35744817
[TBL] [Abstract][Full Text] [Related]
19. Andrographolide attenuates inflammation by inhibition of NF-kappa B activation through covalent modification of reduced cysteine 62 of p50.
Xia YF; Ye BQ; Li YD; Wang JG; He XJ; Lin X; Yao X; Ma D; Slungaard A; Hebbel RP; Key NS; Geng JG
J Immunol; 2004 Sep; 173(6):4207-17. PubMed ID: 15356172
[TBL] [Abstract][Full Text] [Related]
20. Anti-Inflammatory and Anti-Rheumatic Potential of Selective Plant Compounds by Targeting TLR-4/AP-1 Signaling: A Comprehensive Molecular Docking and Simulation Approaches.
Khan A; Khan SU; Khan A; Shal B; Rehman SU; Rehman SU; Htar TT; Khan S; Anwar S; Alafnan A; Rengasamy KR
Molecules; 2022 Jul; 27(13):. PubMed ID: 35807562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
